The UK government has come up with an innovative plan to increase public awareness of the increasing price of prescription drugs and what it costs the healthcare system
Patients in the United Kingdom pay a low flat rate equivalent to $12.80 for each of their prescription medications. Additionally, exemptions available for specific drug categories as well as for patient categories can result in negligence on the part of the patient to be attentive toward the cost of their own healthcare.
Now, the government has come up with an innovative plan to increase public awareness of the increasing price of prescription drugs and what it costs the healthcare system. The Department of Health in the United Kingdom plans to print the "indicative medicine costs" to the National Health Services on the label of all medications that cost more than the equivalent of $31, along with "funded by the UK taxpayer."
Read more at in-Pharma Technologist: http://bit.ly/1C310JO
Study Suggests Adding BTKi to Chemo May Improve Early Outcomes in Richter Transformation in CLL
December 18th 2025The study suggests that adding a Bruton tyrosine kinase inhibitor (BTKi) to frontline chemoimmunotherapy in Richter transformation improved complete response rates and progression-free survival compared with chemoimmunotherapy alone, though overall survival benefits remained unclear.
Read More